Filter
5083
Filtered Results: 5083
Text search:
drug
quality
Featured
Recommendations
460
New Publications
1433
Language
Document type
No document type
3172
Studies & Reports
735
Guidelines
649
Manuals
212
Strategic & Response Plan
146
Fact sheets
66
Training Material
55
Situation Updates
17
Infographics
14
Resource Platforms
9
Brochures
5
Online Courses
2
App
1
Countries / Regions
India
315
Kenya
164
Global
154
South Africa
125
Ethiopia
123
Uganda
120
Western and Central Europe
105
Nigeria
103
Nepal
102
Tanzania
89
Malawi
87
Sierra Leone
85
Liberia
83
Zambia
80
Ghana
73
Africa
69
Bangladesh
69
Myanmar / Burma
68
Latin America and the Carribbean
62
Rwanda
61
Namibia
49
Eastern Europe
47
Ukraine
46
Philippines
41
Cambodia
40
Zimbabwe
39
Lesotho
33
Asia
33
South–East Asia Region
32
Botswana
29
Senegal
27
Congo, Democratic Republic of
27
Russia
25
Indonesia
25
Burkina Faso
21
Syria
20
Mozambique
20
Eswatini/ Swaziland
19
Brazil
18
Haiti
16
East and Southern Africa
15
Cameroon
14
USA
14
West and Central Africa
13
Eastern Europe and Central Asia
13
Tajikistan
11
Germany
11
Middle East and North Africa
11
Georgia
11
South Sudan
11
Colombia
10
Albania
10
Pakistan
10
Thailand
9
Benin
9
Vietnam
9
Afghanistan
8
Venezuela
8
Sudan
8
Laos
7
Guinea
7
North Macedonia
6
Western Pacific Region
6
Moldova
6
China
5
Chile
5
Armenia
5
Paraguay
5
Lebanon
5
Iraq
5
Madagascar
5
Peru
4
Jordan
4
Jamaica
4
United Kingdom
4
Argentina
4
Sri Lanka
4
Mexico
3
El Salvador
3
Turkey
3
Kyrgyzstan
3
Morocco
3
North America
3
Southern Africa
3
Bolivia
3
Bhutan
3
Timor Leste/ East Timor
2
Kazakhstan
2
Iran
2
Fiji
2
Estonia
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Gabon
2
Belgium
2
France
2
Tunisia
2
Portugal
2
Belarus
2
Papua New Guinea
2
Yemen
2
Palestine
2
Central African Republic
2
Poland
2
Mali
2
Libya
2
Somalia
2
Switzerland
1
Serbia
1
Australia
1
Gambia
1
Canada
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Romania
1
Greece
1
Honduras
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
2070
Clinical Guidelines
461
Public Health
258
Women & Child Health
196
Key Resources
101
Pharmacy & Technologies
69
Capacity Building
68
Annual Report MEDBOX
1
Toolboxes
HIV
593
Mental Health
482
TB
468
AMR
275
COVID-19
184
Pharmacy
183
NTDs
136
NCDs
112
Caregiver
106
Rapid Response
75
Planetary Health
66
Refugee
62
Ebola
61
Disability
58
Conflict
53
Global Health Education
51
Health Financing Toolbox
27
Natural Hazards
21
Polio
18
Cholera
14
Social Ethics
14
Zika
11
Specific Hazards
10
Health Financing
1
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
A technical guide for sputum smear microscopy, initiated by the International Union against Tuberculosis, is designed to be an easy to use reference standard for the collection, storage and transport of sputum specimens and for the examination of sputum smears by direct microscopy. This edition incl...
2nd edition. Known as “Community Case Management of Sick Children” (CCM), this approach sends community-based health workers out to find, diagnose, and successfully treat sick children, in partnership with their families. Inspired by the classic “Immunization Essentials”, this guide methodic...
Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a...
The most frequent health problems of newly arrived refugees and migrants include accidental injuries, hypothermia, burns, gastrointestinal illnesses, cardiovascular events, pregnancy- and delivery-related complications, diabetes and hypertension. Female refugees and migrants frequently face specific...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Climate change is damaging human health now and is projected to have a greater impact in the future. Low- and middle-income countries are seeing the worst effects as they are most vulnerable to climate shifts and least able to adapt given weak health systems and poor infrastructure. Low-carbon appro...
